Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growth
- 31 July 2007
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 44 (14), 3453-3461
- https://doi.org/10.1016/j.molimm.2007.03.018
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK‐MLiver International, 2006
- Sepsis-induced suppression of lung innate immunity is mediated by IRAK-MJournal of Clinical Investigation, 2006
- Flow Cytometric Quantification of T Cell Proliferation and Division Kinetics in Woodchuck Model of Hepatitis BImmunological Investigations, 2005
- IL-1 receptor–associated kinase M is a central regulator of osteoclast differentiation and activationThe Journal of Experimental Medicine, 2005
- Transcriptional Regulator CTCF Controls Human Interleukin 1 Receptor-associated Kinase 2 PromoterJournal of Molecular Biology, 2005
- Interleukin receptor–associated kinase (IRAK-4) deficiency associated with bacterial infections and failure to sustain antibody responsesThe Journal of Pediatrics, 2004
- Involvement of IRAK-M in Peptidoglycan-induced Tolerance in MacrophagesPublished by Elsevier ,2004
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004
- Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 2003
- IRAK-M Is a Negative Regulator of Toll-like Receptor SignalingCell, 2002